Arvinas Competitors and Similar CompaniesClear all
Foghorn Therapeutics's competitors and similar companies include Agenus.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. | |
Founding Date | Founding Date 2016 | Founding Date 1994 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US |
Employees | Employees 16135% increase | Employees 38927% decrease |
Valuation ($) | Valuation ($) 534.5 m | Valuation ($) 107.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) $34.2m (FY, 2023) | Revenue (est.) $156.3m (FY, 2023) |
Net income | Net income ($98.4m) (FY, 2023) | Net income ($257.4m) (FY, 2023) |
Funding | ||
Total funding raised | Total funding raised $ 50m | Total funding raised $ 171.1m |
For sources of this data, please see the company profile
View Company Profiles
Agenus
HQ
Lexington, US
Employees
389↓ 27% decrease
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View company